Ameritas Investment Partners’s MacroGenics MGNX Stock Holding History

Ameritas Investment Partners’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,300	Closed	-$8K	–	3285
2025 Q1	$8K	Hold	6,300	–	–	﹤0.01%	2883
2024 Q4	$20.5K	Hold	6,300	–	–	﹤0.01%	2626
2024 Q3	$20.7K	Hold	6,300	–	–	﹤0.01%	2640
2024 Q2	$26.8K	Hold	6,300	–	–	﹤0.01%	2488
2024 Q1	$92.7K	Hold	6,300	–	–	﹤0.01%	1787
2023 Q4	$60.6K	Buy	6,300 +1,801	+40%	+$12.4K	﹤0.01%	2051
2023 Q3	$21K	Hold	4,499	–	–	﹤0.01%	2509
2023 Q2	$24.1K	Hold	4,499	–	–	﹤0.01%	2469
2023 Q1	$32.3K	Hold	4,499	–	–	﹤0.01%	2228
2022 Q4	$26.4K	Hold	4,499	–	–	﹤0.01%	2434
2022 Q3	$15K	Hold	4,499	–	–	﹤0.01%	2647
2022 Q2	$13K	Hold	4,499	–	–	﹤0.01%	2750
2022 Q1	$40K	Hold	4,499	–	–	﹤0.01%	2189
2021 Q4	$72K	Hold	4,499	–	–	﹤0.01%	1896
2021 Q3	$94K	Hold	4,499	–	–	﹤0.01%	1729
2021 Q2	$121K	Hold	4,499	–	–	﹤0.01%	1604
2021 Q1	$143K	Hold	4,499	–	–	0.01%	1433
2020 Q4	$103K	Hold	4,499	–	–	﹤0.01%	1577
2020 Q3	$113K	Buy	4,499 +424	+10%	+$11.6K	0.01%	1358
2020 Q2	$114K	Hold	4,075	–	–	0.01%	1334
2020 Q1	$24K	Hold	4,075	–	–	﹤0.01%	2073
2019 Q4	$44K	Hold	4,075	–	–	﹤0.01%	2000
2019 Q3	$52K	Hold	4,075	–	–	﹤0.01%	1864
2019 Q2	$69K	Buy	4,075 +821	+25%	+$14.1K	﹤0.01%	1720
2019 Q1	$59K	Hold	3,254	–	–	﹤0.01%	1788
2018 Q4	$41K	Hold	3,254	–	–	﹤0.01%	1924
2018 Q3	$70K	Hold	3,254	–	–	﹤0.01%	1783
2018 Q2	$67K	Buy	3,254 +501	+18%	+$11.3K	﹤0.01%	1809
2018 Q1	$69K	Hold	2,753	–	–	﹤0.01%	1727
2017 Q4	$52K	Hold	2,753	–	–	﹤0.01%	1911
2017 Q3	$52K	Hold	2,753	–	–	﹤0.01%	1876
2017 Q2	$48K	Hold	2,753	–	–	﹤0.01%	1931
2017 Q1	$51K	Buy	+2,753	New	+$53.1K	﹤0.01%	1825

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameritas Investment Partners's MGNX Position: Q2 2025 in Review

Ameritas Investment Partners sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 6,300 shares — an estimated $8K sold.

Ameritas Investment Partners first reported a position in MGNX in Q1 2017 and held it in 33 quarters. The position peaked at $143K in Q1 2021. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

Ameritas Investment Partners reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 6,300 MacroGenics shares in Q2 2025, an estimated $8K.
Ameritas Investment Partners first reported a position in MacroGenics in Q1 2017 and held it in 33 quarters.
Ameritas Investment Partners's MacroGenics position peaked at $143K in Q1 2021.
112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.